TMO (Thermo Fisher) חוב לטווח קצר של החברה

Risks for Thermo Fisher Scientific (TMO) are linked to falling demand in China and reductions in biotech budgets. The short-term debt history on the GURU.Markets chart visualizes these challenges, where the value 1.03 captures this metric. Thermo Fisher Scientific (TMO) relies on partnerships with universities for testing, while the recovery of the consumables market and future mergers serve as the primary growth drivers.

Conservative capital demands absolute transparency of the liability structure to assess business resilience. This metric measures the volume of loans maturing within one year, reflecting the efficiency of liquidity management. The stability of cash flows at Thermo Fisher Scientific (TMO) enables the attraction of leading bioengineers, guaranteeing the social significance of their developments. Reducing the debt load minimizes balance sheet risks. By analyzing the organization's short-term debt, an investor determines the balance between solvency and the use of financial leverage.